Cough, Cold and Allergy (hay Fever) Remedies in Israel

Publication Date	May 2009
Publisher	Euromonitor
Product Type	Report
Pages	34
ISBN Number	not applicable
Product Code	EUR00027

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's Cough, Cold and Allergy Products in Israel report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage:

decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, child-specific products, antihistamines

Data coverage:

market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

Get a detailed picture of the cough, cold and allergy (hayfever) industry
Identify factors driving change
Understand the competitive environment, the market's major players and leading brands
Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilniuis, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content

Cough, Cold and Allergy (hay Fever) Remedies in Israel
Euromonitor International
May 2009
List of Contents and Tables
- Executive Summary
- 2008 Continues Positive Growth Rates Similar To the Review Period
- Demand for More Specific Treatments Leads To New Innovations and Launches
- Private Label Benefits From Unique Market Structure
- Gsl Revolution Did Not Bring Expected Results
- Economic Slowdown Aside, Some Sectors Are Expected To See Strong Growth
- Key Trends and Developments
- Unusual Market Structure With OTC Drugs Falling in the "health Basket"
- Increased Private Label Activity
- Specific Drugs Answer Consumer Demand for Specification
- Gsl Revolution Failed To Impact the Retail Market As Expected
- Economic Slowdown Is Expected Only in 2009
- Market Indicators
- Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- Market Data
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Penetration of Private Label by Sector 2003-2008
- Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
- OTC Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Self-medication and Preventive Medicine
- Generics
- Switches
Summary 1 OTC Healthcare Switches 2005-2007
- Definitions
Summary 2 Research Sources
- Dexxon Ltd
- Strategic Direction
- Key Facts
Summary 3 Dexxon Ltd: Key Facts
Summary 4 Dexxon Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 5 Dexxon Ltd: Competitive Position 2008
- New-pharm Drugstores Ltd
- Strategic Direction
- Key Facts
Summary 6 New-Pharm Drugstores Ltd: Key Facts
Summary 7 New-Pharm Drugstores Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
- Rekah Pharmaceutical Products Ltd
- Strategic Direction
- Key Facts
Summary 8 Rekah Pharmaceutical Products Ltd: Key Facts
Summary 9 Rekah Pharmaceutical Products Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 10 Rekah Pharmaceutical Products Ltd: Competitive Position 2008
- Super-pharm (israel) Ltd
- Strategic Direction
- Key Facts
Summary 11 Super Pharm Israel Ltd: Key Facts
Summary 12 Super Pharm Israel Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
- Teva Pharmaceutical Industries Ltd
- Strategic Direction
- Key Facts
Summary 13 Teva Pharmaceutical Industries Ltd: Key Facts
Summary 14 Teva Pharmaceutical Industries Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 15 Teva Pharmaceutical Industries Ltd: Competitive Position 2008
- Trima Israel Pharmaceutical Products Maabarot Ltd
- Strategic Direction
- Key Facts
Summary 16 Trima Israel Pharmaceutical Products Maabarot Ltd: Key Facts
Summary 17 Trima Israel Pharmaceutical Products Maabarot Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 18 Trima Israel Pharmaceutical Products Maabarot Ltd Competitive Position 2008
- Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Sector Data
- Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
- Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
- Table 14 Sales of Decongestants by Type: Value 2003-2008
- Table 15 Sales of Decongestants by Type: % Value Growth 2003-2008
- Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
- Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
- Table 18 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
- Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
- Table 20 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
- Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
- Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013